Concepedia

Esmolol, an ultrashort-acting, selective ?1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties

C. Volz-Zang, B. Eckrich, Patrick Jahn, B. Schneidrowski, B. Schulte, D. Palm

European Journal of Clinical Pharmacology · 1994 · 42 citations · 18 references

DOI

Concepts

References

18

Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite

Check Y. Sum, Avraham Yacobi, Ronald Kartzinel et al. · Clinical Pharmacology & Therapeutics · 1983 · 210 citations

, , +13

Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.

L G Latimer, Philip E. Duffy, Peter W. Kalivas · Journal of Pharmacology and Experimental Therapeutics · 1987 · 152 citations

, , +17

Clinical pharmacology, pharmacodynamics and interactions with esmolol

David Löwenthal, R. Stephen Porter, Steven D. Saris et al. · The American Journal of Cardiology · 1985 · 84 citations

, , +12

Ultra-short-acting .beta.-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent

Paul Erhardt, C. M. WOO, Richard J. Gorczynski et al. · Journal of Medicinal Chemistry · 1982 · 76 citations · Full text

, , +10

Ultra-short-acting .beta.-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function

Paul Erhardt, C. M. WOO, W. Gary Anderson et al. · Journal of Medicinal Chemistry · 1982 · 75 citations · Full text

, , +10